| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 5.62 Billion | USD 10.69 Billion | 7.4% | 2023 |
According to the report published by Zion Market Research, the global Pharmaceutical Gelatin Market size was valued at USD 5.62 Billion in 2023 and is predicted to reach USD 10.69 Billion by the end of 2032. The market is expected to grow with a CAGR of 7.4% during the forecast period. The report analyzes the global Pharmaceutical Gelatin Market's growth drivers, restraints, and impact on demand during the forecast period. It will also help navigate and explore the arising opportunities in the Pharmaceutical Gelati industry.
By partial hydrolysis of collagen derived from the skins, hides, and bones of the animals, a soluble protein called gelatin is obtained. And gelatin to be considered as pharma-medical grade it has to meet certain standards. Pharmaceutical gelatin provides manufacturers of supplements and drugs a versatile excipient which is been widely used in the pharmaceutical industry for decades. Pharmaceutical gelatin is used in numerous pharmaceutical applications such as the production of softgels, hard capsules, tablets, as a stabilizer in vaccines, and many more.
The global pharmaceutical gelatin market is growing at a lucrative rate. Factors that are fueling the growth of the global market include expanding use of gelatin in medical & biomedical applications, growing demand for regenerative medicines, and growing preference of the consumer towards soft gelatin capsules as they are neutral in taste & easy to swallow. Further, for a wide range of therapeutic agents and medicines, gelatin capsules are considered to be a perfect delivery vehicle. Additionally, hydrolyzed gelatin is an important component of blood plasma substitute as it is highly compatible, is biodegradable, does not accumulate in the body, has a short retention time, and molecular behavior & viscosity are similar to blood plasma.
In some vaccines with low endotoxin levels, purified gelatin is used as a stabilizer and offers several benefits such helps to keep lyophilized products stable, ensures patient safety, and reduces the potential for side effects. In addition to this, natural origin, clean label-friendly, body temperature melting-point, biocompatibility, gel-strength, and thermo-reversible are some of the properties of the gelatin which makes it ideal for a wide range of applications in the pharmaceutical industry.
All these factors are spurring the growth of the global pharmaceutical gelatin market. Moreover, the increase in the use of fortified gummies as an alternative delivery system for minerals & vitamins not only for kids but also in the elderly population is also driving the overall market growth. Furthermore, technological advancements to reduce the amount of cross-linking of gelatin in the capsule and enhance its shelf life will have advantageous opportunities for the growth of the global pharmaceutical gelatin market over the forecast period. However, the elevated price of gelatin and easy availability of substitutes may hamper the growth of the global pharmaceutical gelatin market.
During the Covid-19 pandemic, a shortage of gelatin was experienced which affected the global pharmaceutical gelatin market. Drug manufacturers depend on animal sources for gelatin and due to lockdown and restriction on movements, travel curbs abattoirs, and cattle movement, a disruption in this cycle was observed. Additionally, the limitation on personnel movement and a temporary halt on manufacturing units also hampered the productivity of gelatin. Thus, the manufacturing value chain was been hampered in the pandemic period. However, with ease in restrictions and a boom in demand for gelatin in the pharmaceutical is expected to spur the growth of the global market during the forecast period.
The global pharmaceutical gelatin market is divided based on type, function, source, application, and region.
Based on type, the global pharmaceutical gelatin market is split into type A and type B.
The function segment, is bifurcated into gelling agents, thickening agents, stabilizing agents, and others.
Based on sources, Poultry, marine, bovine bone, bovine skin, and porcine are the sources of gelatin.
The application segment consists of absorbable hemostats, tablets, soft capsules, hard capsules, and others.
| Report Attributes | Report Details |
|---|---|
| Report Name | Pharmaceutical Gelatin Market |
| Market Size in 2023 | USD 5.62 Billion |
| Market Forecast in 2032 | USD 10.69 Billion |
| Growth Rate | CAGR of 7.4% |
| Number of Pages | 201 |
| Key Companies Covered | Darling Ingredients Inc., Gelco International, Xiamen Gelken Gelatin Co. Ltd., Italgelatine S.p.A, Lapi Gelatine S.p.A, Trobas Gelatine B.V., Weishardt, Gelita AG, Tessenderlo Group, and Nitta Gelatin Inc, and others |
| Segments Covered | By type, By function, By source, By application and By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2023 |
| Historical Year | 2018 to 2022 |
| Forecast Year | 2024 - 2032 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
North America is estimated to hold the largest share in the global pharmaceutical gelatin market during the forecast period. Growing demand for soft gelatin capsules from the geriatric population, growing use of gelatin for stabilizing agents, and absorbable hemostats are boosting the growth of the market in this region. On the other hand, Asia Pacific is anticipated to grow at a faster rate and is expected to offer ample opportunities for market growth. Some of the factors that are propelling the growth of the market in this region include expanding pharmaceutical industries and the easy availability of gelatin sources.
some of the dominant players that are functioning in the global pharmaceutical gelatin market.
By Type
By function segment
By sources
By application segment
By Region
FrequentlyAsked Questions
Pharmaceutical gelatin is a purified protein used in capsules and drug formulations. It helps in drug delivery and dosage control.
The global Pharmaceutical Gelatin market is expected to be driven by the Driven by growing capsule consumption, rising nutraceutical and dietary supplement demand, and expansion of pharmaceutical manufacturing. Preference for easy-to-swallow dosage forms and improved drug stability supports growth.
According to study, the global Pharmaceutical Gelatin market size was worth around USD 5.62 Billion in 2023 and is predicted to grow to around USD 10.69 Billion By 2032.
The global Pharmaceutical Gelatin market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 7.4% during the forecast period from 2024-2032.
The global Pharmaceutical Gelatin industry is projected to be challenged by Challenges include supply constraints from animal sources, religious/ethical concerns, and strict quality compliance for pharma-grade applications.
The Opportunities include rising capsule consumption, growth in nutraceuticals, and development of improved bovine/fish gelatin and traceability-focused supply chains will offer significant growth opportunities in the Pharmaceutical Gelatin market.
Traceable, high-purity sources and tighter quality controls; recombinant/alternative gel systems where needed; improved capsule performance for sensitive formulations are the emerging trends and innovations impacting the Pharmaceutical Gelatin market.
The global Pharmaceutical Gelatin market is expected to be led by APAC during the forecast period.
Some of the prominent players operating in the global Pharmaceutical Gelatin market are; Darling Ingredients Inc., Gelco International, Xiamen Gelken Gelatin Co. Ltd., Italgelatine S.p.A, Lapi Gelatine S.p.A, Trobas Gelatine B.V., Weishardt, Gelita AG, Tessenderlo Group, and Nitta Gelatin Inc, and others and others.
The report explores crucial aspects of the Pharmaceutical Gelatin market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
HappyClients